![](/img/cover-not-exists.png)
Phase III multicenter randomized study of concurrent twice-a-day radiotherapy with and without cisplatin-5FU (BiRCF) in unresectable pharyngeal carcinoma. 24 months results (FNCLCC-GORTEC)
BENSADOUN, R, BENEZERY, K, RAMAIOLI, A, MAGNE, N, LEMANSKI, C, TORTOCHAUX, J, BOURDIN, S, DASSONVILLE, O, MILANO, G, SCHNEIDER, MVolume:
60
Language:
english
Journal:
International Journal of Radiation OncologyBiologyPhysics
DOI:
10.1016/s0360-3016(04)01136-8
Date:
September, 2004
File:
PDF, 47 KB
english, 2004